Ensayo clínico en reclutamiento = ; Ensayos clínico en curso = ; Financiado por un miembro del IRDiRC =

Ensayo(s) clínico(s) nacional(es)

FRANCIA

ILE-DE-FRANCE
PARIS

Non-Randomized, Open Label Phase II Safety/Efficacy Study: Replace Sandostatine® in Three Daily Subcutaneous Injections by a Single Intramuscular Injection of Sandostatine® LP Per Month in Patients With a Diffuse Form of Hyperinsulinism

CHU Paris - Hôpital Necker-Enfants Malades

Service des Maladies Métaboliques pédiatriques

Para más detalles

REINO UNIDO (EL)

Greater Manchester
MANCHESTER

The effect of purified fish oils on glucose regulation in Congenital Hyperinsulinism of Infancy - CHI (Phase II) (Completed)

Royal Manchester Children's Hospital

Department of Endocrinology

Para más detalles

ESTADOS UNIDOS

Pennsylvania
PHILADELPHIA

Role of GLP-1 In Congenital Hyperinsulinism: Effect of Exendin-(9-39) on Glucose Requirements To Maintain Euglycemia (Phase 1/2) - US

The Children's Hospital of Philadelphia

Center of Congenital Hyperinsulinism

Para más detalles